OncoSec Medical Incorporated, based in San Diego, CA, is a biotechnology company focused on developing innovative cancer therapies. Their lead product candidate, TAVO, utilizes intratumoral administration of IL-12 to stimulate systemic immune responses and potentially revolutionize cancer treatment.
With a core technology platform advancing through clinical trials for various cancers, OncoSec is dedicated to arming the immune system to target and attack cancer cells. Through strategic partnerships and a commitment to new approaches, OncoSec is at the forefront of developing cutting-edge therapies to fight tumors directly.
Generated from the website